Whole blood RNA profiling of severe COVID-19 cases

Whole blood RNA profiling of severe COVID-19 cases

24/08/2022 Osaka University

Researchers from Osaka University evaluate RNA profiles in the blood to shed light on the signaling pathways underlying the pathogenesis of COVID-19

Osaka, Japan – Just as a recipe contains the instructions needed to make a dish, messenger ribonucleic acid (mRNA) sequences in the body contain the information needed to make proteins. Changes in the expression of specific mRNAs and short RNA sequences known as microRNAs, which can act to suppress protein synthesis, may accompany disease. Recently, researchers in Japan have uncovered changes in mRNA and microRNA expression patterns that occur in the blood during severe COVID-19 infection.
In a new study published in Molecular Therapy Nucleic Acids, researchers led by Osaka University comprehensively analyzed the mRNA and microRNA profiles of whole blood samples from patients with severe COVID-19 using a technique known as RNA-sequencing. RNA-sequencing allows for the evaluation of all of the RNA content expressed within a population of cells.
As COVID-19 continues to affect the global population, further insight into the mechanisms underlying the pathogenesis of COVID-19, i.e., how COVID-19 progresses in the body, is needed. To this end, the Osaka University-led research team sought to examine RNA expression in the blood of patients with severe COVID-19 to determine how mRNA and microRNA expression profiles are affected by COVID-19.
“We collected whole blood samples from critically ill COVID-19 patients and healthy controls and performed RNA-sequencing to evaluate differences in mRNA and microRNA expression,” says lead author of the study, Yuki Togami.
RNA-sequencing analysis revealed specific mRNAs and microRNAs that were differentially expressed between severely ill patients with COVID-19 and healthy controls. Integrated analysis of mRNA and microRNA expression profiles further showed that an immune response pathway known as the interferon signaling pathway was activated in patients with severe COVID-19.
“On the basis of the results of our analysis, we measured interferon protein levels in patient plasma and found notable differences in the expression of two interferon pathway members, interferon-β and interferon-λ1,” says senior author, Hiroshi Ogura.
Interferon-β was found to be elevated in COVID-19 patients in a manner that corresponded with illness severity, while interferon-λ1 expression was higher in non-critically ill patients compared with healthy controls, but lower in critically ill patients compared with non-critically ill patients. The research team’s findings indicate that interferon-β and interferon-λ1 play an important role in the severity of COVID-19. Enhanced understanding of the cellular mechanisms underlying COVID-19 pathogenesis may aid in the development of therapeutics to treat severe COVID-19.
The article, “Significance of interferon signaling based on mRNA-microRNA integration and plasma protein analyses in critically ill COVID-19 patients,” was published in Molecular Therapy Nucleic Acids at DOI: https://doi.org/10.1016/j.omtn.2022.07.005.
Title: Significance of interferon signaling based on mRNA-microRNA integration and plasma protein analyses in critically ill COVID-19 patients
Journal: Molecular Therapy-Nucleic Acids
Authors: Yuki Togami, Hisatake Matsumoto, Jumpei Yoshimura, Tsunehiro Matsubara, Takeshi Ebihara, Hiroshi Matsuura, Yumi Mitsuyama, Takashi Kojima, Masakazu Ishikawa, Fuminori Sugihara, Haruhiko Hirata, Daisuke Okuzaki, Hiroshi Ogura
DOI: 10.1016/j.omtn.2022.07.005
Funded by: Japan Agency for Medical Research and Development, Takeda Science Foundation
Article publication date: 13-Jul-2022
Attached files
  • Outline of this study (CC BY-NC-ND, 2022 Yuki Togami et al., Significance of interferon signaling based on mRNA-microRNA integration and plasma protein analyses in critically ill COVID-19 patients, Molecular Therapy-Nucleic Acids)
24/08/2022 Osaka University
Regions: Asia, Japan
Keywords: Covid-19, Covid-19


For well over a decade, in my capacity as a researcher, broadcaster, and producer, I have relied heavily on Alphagalileo.
All of my work trips have been planned around stories that I've found on this site.
The under embargo section allows us to plan ahead and the news releases enable us to find key experts.
Going through the tailored daily updates is the best way to start the day. It's such a critical service for me and many of my colleagues.
Koula Bouloukos, Senior manager, Editorial & Production Underknown
We have used AlphaGalileo since its foundation but frankly we need it more than ever now to ensure our research news is heard across Europe, Asia and North America. As one of the UK’s leading research universities we want to continue to work with other outstanding researchers in Europe. AlphaGalileo helps us to continue to bring our research story to them and the rest of the world.
Peter Dunn, Director of Press and Media Relations at the University of Warwick
AlphaGalileo has helped us more than double our reach at SciDev.Net. The service has enabled our journalists around the world to reach the mainstream media with articles about the impact of science on people in low- and middle-income countries, leading to big increases in the number of SciDev.Net articles that have been republished.
Ben Deighton, SciDevNet

We Work Closely With...

  • BBC
  • The Times
  • National Geographic
  • The University of Edinburgh
  • University of Cambridge
Copyright 2022 by AlphaGalileo Terms Of Use Privacy Statement